LWMI
RDY icon

Legacy Wealth Management (Idaho)’s Dr. Reddy's Laboratories RDY Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$208 Hold
15
– – ﹤0.01% 986
2025
Q4 		$211 Hold
15
– – ﹤0.01% 867
2025
Q3 		$210 Hold
15
– – ﹤0.01% 735
2025
Q2 		$226 Hold
15
– – ﹤0.01% 700
2025
Q1 		$198 Hold
15
– – ﹤0.01% 770
2024
Q4 		$209 Sell
15
-60
-80% -$901 ﹤0.01% 715
2024
Q3 		$219 Buy
+75
New +$1.21K ﹤0.01% 664

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Legacy Wealth Management (Idaho)'s RDY Position: Q1 2026 in Review

Legacy Wealth Management (Idaho) held its Dr. Reddy's Laboratories (RDY) position steady in Q1 2026 at 15 shares worth $208. The position accounts for ﹤0.01% of the portfolio, ranked #986.

Legacy Wealth Management (Idaho) first reported a position in RDY in Q3 2024 and has held it in 7 quarters since. The position peaked at $226 in Q2 2025. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Legacy Wealth Management (Idaho) held 15 shares of Dr. Reddy's Laboratories worth $208 as of Q1 2026.
  • Legacy Wealth Management (Idaho) left its Dr. Reddy's Laboratories share count unchanged in Q1 2026.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Legacy Wealth Management (Idaho)'s portfolio in Q1 2026, its #986 holding.
  • Legacy Wealth Management (Idaho) first reported a position in Dr. Reddy's Laboratories in Q3 2024 and has held it in 7 quarters since.
  • Legacy Wealth Management (Idaho)'s Dr. Reddy's Laboratories position peaked at $226 in Q2 2025.
  • 247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q1 2026, filed 7 May 2026.